semnurpharma.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow:

Meta Tags

Title	Semnur
Description	Semnur Pharmaceuticals primary focus lies in the development of non-opioid products for meeting the needs of under served patients with back
Keywords	N/A

Server Information

WebSite	semnurpharma.com
Host IP	67.205.31.16
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

semnurpharma.com Valuation

US$971,027

Last updated: 2023-05-14 01:15:54

semnurpharma.com has Semrush global rank of 10,900,116. semnurpharma.com has an estimated worth of US$ 971,027, based on its estimated Ads revenue. semnurpharma.com receives approximately 112,042 unique visitors each day. Its web server is located in United States, with IP address 67.205.31.16. According to SiteAdvisor, semnurpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$971,027
Daily Ads Revenue	US$897
Monthly Ads Revenue	US$26,890
Yearly Ads Revenue	US$322,680
Daily Unique Visitors	7,470
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
semnurpharma.com.	A	3599	IP: 67.205.31.16
semnurpharma.com.	NS	3600	NS Record: ns2.ipage.com.
semnurpharma.com.	NS	3600	NS Record: ns1.ipage.com.
semnurpharma.com.	MX	3600	MX Record: 0 semnurpharma-com.mail.protection.outlook.com.
semnurpharma.com.	TXT	3600	TXT Record: googlea8475fa3d688d053
semnurpharma.com.	TXT	3600	TXT Record: MS=ms71139981
semnurpharma.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com ~all

HtmlToTextCheckTime:2023-05-14 01:15:54

Sorrento Therapeutics Announces the Merger of Scilex and Semnur to Create a Global Leader in Non-Opioid Pain Management". click Semnur Pharmaceuticals ™ Getting Back to Normal Menu About Management Chronic Back Pain Clinical Study News Contact Search Search for: Semnur Pharmaceuticals has started a Phase 3 study for the treatment of lumbar radicular pain, commonly known as sciatica and has received fast track status from the FDA for the novel injectable gel formulation (SP-102) in development. Learn more SP-102 is the first non-opioid novel injectable gel formulation in development for the treatment of lumbar radicular pain/sciatica, containing no neurotoxic preservatives, surfactants, solvents or particulates. Learn more We are currently advancing a portfolio of non-opioid novel injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Learn more Contact Privacy Policy Terms of Use ©2023 Semnur

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 22 Dec 2021 12:03:31 GMT
Server: Apache
Location: https://www.semnurpharma.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
date: Wed, 22 Dec 2021 12:03:31 GMT
server: Apache
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
cache-control: max-age=600
expires: Wed, 22 Dec 2021 12:13:31 GMT
vary: User-Agent
content-type: text/html; charset=UTF-8

semnurpharma.com Whois Information

Domain Name: SEMNURPHARMA.COM
Registry Domain ID: 1818039307_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domain.com
Registrar URL: http://www.domain.com
Updated Date: 2021-07-13T15:39:05Z
Creation Date: 2013-07-28T00:02:16Z
Registry Expiry Date: 2022-07-28T00:02:16Z
Registrar: Domain.com, LLC
Registrar IANA ID: 886
Registrar Abuse Contact Email: compliance@domain-inc.net
Registrar Abuse Contact Phone: 602-226-2389
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.IPAGE.COM
Name Server: NS2.IPAGE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-25T08:15:53Z <<<

semnurpharma.com valuation and analysis